Skip to content

Effect of vitamin D in autism spectrum disorder: A clinical trial

Efficacy of vitamin D in augmenting behavioral intervention in children with autism spectrum disorder: a randomized placebo controlled double blinded trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/09/021079
Enrollment
160
Registered
2019-09-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F840- Autistic disorder

Interventions

Intervention1: Oral vitamin D 60,000 IU: Oral vitamin D 60,000 IU once in 2 weeks + parent mediated interventions for 12 weeks (60000IU Oral Vit D sachets once in 14 days for 12 weeks) Control Interv

Sponsors

ICMR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Newly diagnosed patients with autism spectrum disorder 2.All consecutive children between age 3-8 years attending the Child Psychiatry Clinic, JIPMER hospital, with a diagnosis of Autism Spectrum Disorder as per DSM 5

Exclusion criteria

Exclusion criteria: 1.Patient on vitamin D-based therapy within 6 months prior to screening. 2.Patients with symptomatic vitamin D deficiency 3.Patient with a history of allergy or sensitivity to vitamin D or its analogues. 4.Patients with coexisting diseases, such as, chronic gastrointestinal disease, myocardial infarction, cerebrovascular accident, congestive heart failure, cardiomyopathies, peripheral vascular diseases, malignancies and renal stones. 5.Patient has received any investigational drug 6.Patient on any drugs modulating calcium metabolism and homeostasis

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of combination therapy of oral vitamin D supplementation and parent-mediated behavioral interventions to parent-mediated behavioral interventions and placebo for three months in children (4-12 years) with autism spectrum disorder using CARS 2 (Childhood autism rating scale)Timepoint: 3months

Secondary

MeasureTime frame
To generate the frequency of VDR gene polymorphisms [ApaI (rs7975232), BsmI (rs1544410), TaqI (TC; rs731236), FokI (CT; rs2228570)] in children with autism spectrum disorder and to evaluate their effect on response to vitamin D therapyTimepoint: 3 months

Countries

India

Contacts

Public ContactSandhiya S

JIPMER

sandhiyaselvarajan@gmail.com9443492922

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026